A Review of immunomodulators with reference to Canova - Similima
A Review of immunomodulators with reference to Canova - Similima
A Review of immunomodulators with reference to Canova - Similima
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
In sarcoma - <strong>Canova</strong> treated mice showed delay in<br />
development & reduction in size <strong>of</strong> the tumor, increased<br />
infiltration <strong>of</strong> lymphoid cells, GT & fibrosis sorrounding the<br />
tumor, Leucocy<strong>to</strong>sis & Lymphocy<strong>to</strong>sis ( enhanced immune<br />
response) compared <strong>to</strong> control group<br />
Macrophages showed 86% activation in <strong>Canova</strong> treated & 15%<br />
activation in control<br />
TNF alpha production was decreased while IL2 & IFN gamma<br />
revealed no difference <strong>with</strong> control group<br />
www.similima.com 14
Change language